Jaydeep Sinha, MPharm, PhD (he/him/his)

Associate Director, Quantitative Clinical Pharmacology
Daiichi-Sankyo, Inc., USA

Poster(s):

• (T-100) Exposure-Response Analysis of Datopotamab Deruxtecan (Dato-DXd) in Combination with Pembrolizumab with or without Platinum Chemotherapy in Patients with Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT